Displaying 1 - 20 of 66 results
Released Company Title Industry Topic
04 Aug 2020
07:00 CEST
VIVORYON Vivoryon Therapeutics AG: Vivoryon Receives IND Approval for Varoglutamstat's (PQ912) Phase 2 Study in Alzheimer's Disease 20103010 Biotechnology Other subject
15 Jul 2020
07:00 CEST
VIVORYON Vivoryon Therapeutics AG: Vivoryon Therapeutics Announces Enrollment of First Patient in VIVIAD, European Phase 2b Alzheimer's Disease Study with Varoglutamstat (PQ912) 20103010 Biotechnology Trends / Analyses
26 Jun 2020
07:00 CEST
VIVORYON Vivoryon Therapeutics AG: Vivoryon Therapeutics Provides Update on US and EU Alzheimer's Clinical Trial Program with PQ912 20103010 Biotechnology Other subject
14 May 2020
07:00 CEST
VIVORYON Vivoryon Therapeutics AG: Vivoryon Therapeutics AG Reports First Quarter 2020 Biotechnology Commercial results
12 May 2020
07:00 CEST
VIVORYON Vivoryon Therapeutics AG: Vivoryon Therapeutics AG Postpones Annual General Meeting Biotechnology General meeting / Board Meeting
07 May 2020
07:00 CEST
VIVORYON Vivoryon Therapeutics AG: Vivoryon Therapeutics AG to Publish its First Quarter 2020 Business Update on May 14, 2020 Biotechnology Other subject
29 Apr 2020
07:00 CEST
VIVORYON Vivoryon Therapeutics AG: Vivoryon Therapeutics Announces Outcome of Exclusive Option Deal with MorphoSys Biotechnology Other subject
16 Apr 2020
07:00 CEST
VIVORYON Vivoryon Therapeutics AG: Vivoryon Therapeutics Starts Development Program for Meprin Protease Inhibitors with Intended Therapeutic Use in Fibrosis, Cancer and Alzheimer's Disease Biotechnology Legal
26 Mar 2020
13:10 CET
VIVORYON Correction of a release from 26/03/2020, 07:00 CET/CEST - Vivoryon Therapeutics AG: Vivoryon Therapeutics AG Reports Full Year 2019 Financial Results Biotechnology Commercial results
26 Mar 2020
07:00 CET
VIVORYON Vivoryon Therapeutics AG: Vivoryon Therapeutics AG Reports Full Year 2019 Financial Results Biotechnology Commercial results
19 Mar 2020
07:00 CET
VIVORYON Vivoryon Therapeutics AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] Biotechnology Other subject
19 Mar 2020
07:00 CET
VIVORYON Vivoryon Therapeutics AG: Vivoryon Therapeutics AG to Publish its Full Year 2019 Results on March 26, 2020 Biotechnology Other subject
18 Mar 2020
07:00 CET
VIVORYON Vivoryon Therapeutics AG: Vivoryon Therapeutics Announces Update on Phase 2b Alzheimer's Clinical Trial, VIVIAD Biotechnology Trends / Analyses
03 Mar 2020
07:00 CET
VIVORYON Vivoryon Therapeutics AG: Vivoryon Therapeutics to Attend Upcoming Investor Conferences Biotechnology Meetings / events
14 Jan 2020
07:00 CET
VIVORYON Vivoryon Therapeutics AG: Vivoryon Therapeutics and Nordic Bioscience Enter Research and Development Collaboration Biotechnology News contracts
07 Jan 2020
07:00 CET
VIVORYON Vivoryon Therapeutics AG: Vivoryon Therapeutics to Attend 38th Annual J.P. Morgan Healthcare Conference in January 2020 Biotechnology Meetings / events
20 Dec 2019
07:00 CET
VIVORYON Vivoryon Therapeutics AG: Vivoryon Therapeutics is Included in AScX Index Biotechnology Other subject
28 Nov 2019
07:00 CET
VIVORYON Vivoryon Therapeutics AG: Vivoryon Therapeutics Reports Third Quarter 2019 Biotechnology Other subject
27 Nov 2019
12:00 CET
VIVORYON Vivoryon Therapeutics AG: Vivoryon Therapeutics attends CTAD 2019 Biotechnology Meetings / events
21 Nov 2019
07:00 CET
VIVORYON Vivoryon Therapeutics AG: Vivoryon Therapeutics AG to Publish Third Quarter 2019 Results on November 28, 2019 Biotechnology Other subject